The therapeutic potential of modulating the ceramide/sphingomyelin pathway

Journal of Clinical Investigation

Volumn 110, Issue 1, 2002, Pages 3-8

  Kolesnick, Richard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; SPHINGOMYELIN;

APOPTOSIS; BIOSYNTHESIS; ENZYME ACTIVATION; METABOLISM; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0036303786     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216127     Document Type: Review

References (61)

1. Sphingomyelin and derivatives as cellular signals
2. 3 pituitary cells
3. 3 pituitary cells: Evidence for involvement of a sphingomyelinase
4. Sphingomyelinase action inhibits phorbol ester-induced differentiation of human promyelocytic leukemic (HL-60) cells
5. 3 in HL-60 cells: Role in cell differentiation
6. 3-induced HL-60 cell differentiation
7. Enzymes of sphingolipid metabolism: From modular to integrative signaling
8. Signal transduction of stress via ceramide
9. Molecular mechanisms of ceramide-mediated CD95 clustering
10. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene
11. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development
12. Compartmentalized production of ceramide at the cell surface
13. Acid sphingomyelinase deficient mice: A model of types A and B Niemann-Pick disease
14. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death
15. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha
16. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
17. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals
18. Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase
19. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes
20. Molecular cloning and functional characterization of murine sphingosine kinase
21. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform
22. Suppression of ceramide-mediated programmed cell death by sphingosine 1-phosphate
23. Sphingosine-1-phosphate as 2nd messenger in cell proliferation induced by PDGF and FCS mitogens
24. Lysophospholipids: Receptor revelations
25. Molecular cloning and characterization of a human mitochondrial ceramidase
26. Compartmentalization of ceramide signaling: Physical foundations and biological effects
27. How cells handle cholesterol
28. Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro
29. The 1999 Moyer award. Burn injury induces skeletal muscle apoptosis and the activation of caspase pathways in rats
30. Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae
31. Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress
32. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
33. Molecular ordering of the initial signaling events of CD95
34. The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells
35. An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes
36. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-I
37. Kinase suppressor of Ras is ceramide-activated protein kinase
38. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells
39. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release
40. Cathepsin D targeted by acid sphingomyelinase-derived ceramide
41. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid
42. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR)
43. Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase
44. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells
45. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A
46. KSR: A MAPK scaffold of the Ras pathway?
47. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha
48. Importance of C1B domain for lipid messenger-induced targeting of protein kinase C
49. Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries
50. Inhibitory actions of ceramide upon PKC-epsilon/ERK interactions
51. Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line
52. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer
53. A comprehensive study of the radiobiological response of the murine (BDF1) small intestine
54. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice
55. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy
56. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism
57. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase
58. A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin
59. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
60. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression
61. Ceramide-rich membrane rafts mediate CD40 clustering